Bio-Rad to Acquire AbD Serotec for $69.7M
December 17, 2012
Bio-Rad to Acquire AbD Serotec for $69.7M
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Bio-Rad Completes $70M Acquisition of AbD Serotec
January 10, 2013 / GenomeWeb Daily News - Morphosys Extends Research Agreement with Pharma Firm Shionogi
November 11, 2011 / ProteoMonitor - Morphosys Inks Deal with Moredun, Roslin to Develop Protein Reagents for Veterinary Research
October 21, 2011 / ProteoMonitor - Bio-Rad Acquires QuantaLife for $162M
October 5, 2011 / GenomeWeb Daily News - Merck To Use Morphosys' HuCAL Gold Antibodies in Vaccine Research
August 5, 2011 / ProteoMonitor